Organisation paid for research Program year 2024 Source: CMS Open Payments

Vanguard Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$8,250

3 payments

Through program year 2024, Vanguard Clinical Research is reported as receiving $8,250 in research payments, across 3 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$1,250	1
2021	Research	$800	1
2020	Research	$6,200	1

Breakdown

Who paid Research payments · program years 2020–2024

Sanofi US Services Inc. $8,250 3 payments

Studies the money was for Research payments · program years 2020–2024

A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation $6,200 1 payment
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Pivotal Study to Assess the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation $2,050 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.